XML 56 R42.htm IDEA: XBRL DOCUMENT
v3.23.3

Adjustments to quarterly financial data (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Accounting Changes and Error Corrections [Abstract] |
Schedule of Error Corrections and Prior Period Adjustments | The following tables present the impact of the financial statement adjustments on the Company's previously reported Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2022:
|  | As of
|  | September 30, 2022
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
ASSETS |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 240.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 240.9 |
Restricted cash |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Accounts receivable, net |  | 191.3 |  |  | — |  |  | (2.1) |  |  | 189.2 |
Inventories, net |  | 546.3 |  |  | — |  |  | (18.1) |  |  | 528.2 |
Prepaid expenses and other current assets |  | 139.9 |  |  | — |  |  | — |  |  | 139.9 |
Total current assets |  | 1,118.5 |  |  | — |  |  | (20.2) |  |  | 1,098.3 |
Property, plant and equipment, net |  | 806.7 |  |  | — |  |  | 0.1 |  |  | 806.8 |
Intangible assets, net |  | 722.7 |  |  | — |  |  | 2.2 |  |  | 724.9 |
Goodwill |  | 224.9 |  |  | — |  |  | — |  |  | 224.9 |
Other assets |  | 35.7 |  |  | — |  |  | 5.1 |  |  | 40.8 |
Total assets |  | $ | 2,908.5 |  |  | $ | — |  |  | $ | (12.8) |  |  | $ | 2,895.7 |
LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 103.8 |  |  | $ | — |  |  | $ | (2.8) |  |  | $ | 101.0 |
Accrued expenses |  | 35.9 |  |  | — |  |  | (0.2) |  |  | 35.7 |
Accrued compensation |  | 82.5 |  |  | — |  |  | — |  |  | 82.5 |
Debt, current portion |  | 21.2 |  |  | — |  |  | — |  |  | 21.2 |
Other current liabilities |  | 25.0 |  |  | (0.7) |  |  | (0.3) |  |  | 24.0 |
Total current liabilities |  | 268.4 |  |  | (0.7) |  |  | (3.3) |  |  | 264.4 |
Debt, net of current portion |  | 1,032.1 |  |  | — |  |  | — |  |  | 1,032.1 |
Deferred tax liability |  | 113.8 |  |  | 0.1 |  |  | — |  |  | 113.9 |
Other liabilities |  | 44.9 |  |  | 6.5 |  |  | 0.9 |  |  | 52.3 |
Total liabilities |  | 1,459.2 |  |  | 5.9 |  |  | (2.4) |  |  | 1,462.7 |
Stockholders’ equity: |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 15.0 shares authorized, no shares issued and outstanding |  | — |  |  | — |  |  | — |  |  | — |
Common stock, $0.001 par value; 200.0 shares authorized, 55.5 shares issued; 49.9 shares outstanding |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Treasury stock, at cost, 5.6 common shares |  | (227.7) |  |  | — |  |  | — |  |  | (227.7) |
Additional paid-in capital |  | 860.1 |  |  | — |  |  | — |  |  | 860.1 |
Accumulated other comprehensive income (loss), net |  | (5.2) |  |  | — |  |  | — |  |  | (5.2) |
Retained earnings |  | 822.0 |  |  | (5.9) |  |  | (10.4) |  |  | 805.7 |
Total stockholders’ equity |  | 1,449.3 |  |  | (5.9) |  |  | (10.4) |  |  | 1,433.0 |
Total liabilities and stockholders’ equity |  | $ | 2,908.5 |  |  | $ | — |  |  | $ | (12.8) |  |  | $ | 2,895.7 |
|  | As of
|  | December 31, 2022
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
ASSETS |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 642.6 |  |  | $ | — |  |  | $ | — |  |  | $ | 642.6 |
Restricted cash |  | — |  |  | — |  |  | — |  |  | — |
Accounts receivable, net |  | 158.4 |  |  | — |  |  | 0.8 |  |  | 159.2 |
Inventories, net |  | 351.8 |  |  | — |  |  | (1.1) |  |  | 350.7 |
Prepaid expenses and other current assets |  | 57.9 |  |  | — |  |  | — |  |  | 57.9 |
Total current assets |  | 1,210.7 |  |  | — |  |  | (0.3) |  |  | 1,210.4 |
Property, plant and equipment, net |  | 817.6 |  |  | — |  |  | — |  |  | 817.6 |
Intangible assets, net |  | 728.8 |  |  | — |  |  | — |  |  | 728.8 |
Goodwill |  | 218.2 |  |  | — |  |  | — |  |  | 218.2 |
Other assets |  | 191.3 |  |  | — |  |  | — |  |  | 191.3 |
Total assets |  | $ | 3,166.6 |  |  | $ | — |  |  | $ | (0.3) |  |  | $ | 3,166.3 |
LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 103.5 |  |  | $ | — |  |  | $ | — |  |  | $ | 103.5 |
Accrued expenses |  | 34.9 |  |  | — |  |  | — |  |  | 34.9 |
Accrued compensation |  | 88.3 |  |  | — |  |  | (1.0) |  |  | 87.3 |
Debt, current portion |  | 957.3 |  |  | — |  |  | — |  |  | 957.3 |
Other current liabilities |  | 45.9 |  |  | (0.3) |  |  | 0.3 |  |  | 45.9 |
Total current liabilities |  | 1,229.9 |  |  | (0.3) |  |  | (0.7) |  |  | 1,228.9 |
Debt, net of current portion |  | 448.5 |  |  | — |  |  | — |  |  | 448.5 |
Deferred tax liability |  | 71.8 |  |  | (12.1) |  |  | — |  |  | 59.7 |
Other liabilities |  | 33.4 |  |  | 7.1 |  |  | 1.0 |  |  | 41.5 |
Total liabilities |  | 1,783.6 |  |  | (5.3) |  |  | 0.3 |  |  | 1,778.6 |
Stockholders’ equity: |  |  |  |  |  |  |  |
Preferred stock, $0.001 par value; 15.0 shares authorized, no shares issued and outstanding |  | — |  |  | — |  |  | — |  |  | — |
Common stock, $0.001 par value; 200.0 shares authorized, 55.7 shares issued; 50.1 shares outstanding |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Treasury stock, at cost, 5.6 common shares |  | (227.7) |  |  | — |  |  | — |  |  | (227.7) |
Additional paid-in capital |  | 873.5 |  |  | — |  |  | — |  |  | 873.5 |
Accumulated other comprehensive income (loss), net |  | 3.1 |  |  | — |  |  | — |  |  | 3.1 |
Retained earnings |  | 734.0 |  |  | 5.3 |  |  | (0.6) |  |  | 738.7 |
Total stockholders’ equity |  | 1,383.0 |  |  | 5.3 |  |  | (0.6) |  |  | 1,387.7 |
Total liabilities and stockholders’ equity |  | $ | 3,166.6 |  |  | $ | — |  |  | $ | (0.3) |  |  | $ | 3,166.3 |
The following tables present the impact of the financial statement adjustments on the Company's previously reported Quarterly Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022:
| Three Months Ended
| September 30, 2022
| Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
Revenues: |  |  |  |  |  |  |
Product sales, net | $ | 186.2 |  |  | $ | — |  | $ | — |  |  | $ | 186.2 |
CDMO: |  |  |  |  |  |  |
Services | 36.2 |  |  | — |  |  | (0.1) |  |  | 36.1 |
Leases | 0.2 |  |  | — |  |  | — |  |  | 0.2 |
Total CDMO revenues | 36.4 |  |  | — |  |  | (0.1) |  |  | 36.3 |
Contracts and grants | 17.4 |  |  | — |  |  | — |  |  | 17.4 |
Total revenues | 240.0 |  |  | — |  |  | (0.1) |  |  | 239.9 |
Operating expenses: |  |  |  |  |  |  |
Cost of product sales | 85.5 |  |  | — |  |  | (0.3) |  |  | 85.2 |
Cost of CDMO | 63.1 |  |  | — |  |  | (1.1) |  |  | 62.0 |
Research and development | 39.2 |  |  | — |  |  | 3.0 |  |  | 42.2 |
Selling, general and administrative | 80.2 |  |  | — |  |  | 1.6 |  |  | 81.8 |
Amortization of intangible assets | 14.0 |  |  | — |  |  | — |  |  | 14.0 |
Total operating expenses | 282.0 |  |  | — |  |  | 3.2 |  |  | 285.2 |
Loss from operations | (42.0) |  |  | — |  |  | (3.3) |  |  | (45.3) |
Other income (expense): |  |  |  |  |  |  |
Interest expense | (8.5) |  |  | — |  |  | — |  |  | (8.5) |
Other, net | (13.4) |  |  | — |  |  | — |  |  | (13.4) |
Total other income (expense), net | (21.9) |  |  |  |  | — |  |  | (21.9) |
Loss before income taxes | (63.9) |  |  | — |  |  | (3.3) |  |  | (67.2) |
Income tax provision (benefit) | 11.8 |  |  | 8.1 |  |  | — |  |  | 19.9 |
Net loss | $ | (75.7) |  |  | $ | (8.1) |  |  | $ | (3.3) |  |  | $ | (87.1) |
Net loss per common share |  |  |  |  |  |  |
Basic | $ | (1.52) |  |  | $ | (0.16) |  |  | $ | (0.07) |  |  | $ | (1.75) |
Diluted | $ | (1.52) |  |  | $ | (0.16) |  |  | $ | (0.07) |  |  | $ | (1.75) |
Weighted average shares outstanding |  |  |  |  |  |  |
Basic | 49.9 |  |  | — |  |  | — |  |  | 49.9 |
Diluted | 49.9 |  |  | — |  |  | — |  |  | 49.9 |
| Nine Months Ended
| September 30, 2022
| Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
Revenues: |  |  |  |  |  |  |
Product sales, net | $ | 660.5 |  |  | $ | — |  |  | $ | — |  |  | $ | 660.5 |
CDMO: |  |  |  |  |  |  |
Services | 90.7 |  |  | — |  |  | (2.9) |  |  | 87.8 |
Leases | 4.7 |  |  | — |  |  | — |  |  | 4.7 |
Total CDMO revenues | 95.4 |  |  | — |  |  | (2.9) |  |  | 92.5 |
Contracts and grants | 34.3 |  |  | — |  |  | — |  |  | 34.3 |
Total revenues | 790.2 |  |  | — |  |  | (2.9) |  |  | 787.3 |
Operating expenses: |  |  |  |  |  |  |
Cost of product sales | 256.8 |  |  | — |  |  | — |  |  | 256.8 |
Cost of CDMO | 217.5 |  |  | — |  |  | (1.7) |  |  | 215.8 |
Research and development | 135.4 |  |  | — |  |  | 5.9 |  |  | 141.3 |
Selling, general and administrative | 246.1 |  |  | — |  |  | — |  |  | 246.1 |
Amortization of intangible assets | 42.0 |  |  | — |  |  | — |  |  | 42.0 |
Total operating expenses | 897.8 |  |  | — |  |  | 4.2 |  |  | 902.0 |
Loss from operations | (107.6) |  |  | — |  |  | (7.1) |  |  | (114.7) |
Other income (expense): |  |  |  |  |  |  |
Interest expense | (24.5) |  |  |  |  | — |  |  | (24.5) |
Other, net | (18.4) |  |  |  |  | — |  |  | (18.4) |
Total other income (expense), net | (42.9) |  |  | — |  |  | — |  |  | (42.9) |
Loss before income taxes | (150.5) |  |  | — |  |  | (7.1) |  |  | (157.6) |
Income tax provision (benefit) | (14.7) |  |  | 1.7 |  |  | — |  |  | (13.0) |
Net loss | $ | (135.8) |  |  | $ | (1.7) |  |  | $ | (7.1) |  |  | $ | (144.6) |
Net loss per common share |  |  |  |  |  |  |
Basic | $ | (2.71) |  |  | $ | (0.03) |  |  | $ | (0.14) |  |  | $ | (2.88) |
Diluted | $ | (2.71) |  |  | $ | (0.03) |  |  | $ | (0.14) |  |  | $ | (2.88) |
Weighted average shares outstanding |  |  |  |  |  |  |
Basic | 50.2 |  |  | — |  |  | — |  |  | 50.2 |
Diluted | 50.2 |  |  | — |  |  | — |  |  | 50.2 |
The following table presents the impact of the financial statement adjustments on the Company's previously reported Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022:
|  | Nine Months Ended
|  | September 30, 2022
|  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Restated
Operating Activities |  |  |  |  |  |  |  |
Net loss |  | $ | (135.8) |  |  | $ | (1.7) |  |  | $ | (7.1) |  |  | $ | (144.6) |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |
Stock-based compensation expense |  | 33.4 |  |  | — |  |  | — |  |  | 33.4 |
Depreciation and amortization |  | 107.7 |  |  | — |  |  | (0.1) |  |  | 107.6 |
Change in fair value of contingent obligations, net |  | 2.4 |  |  | — |  |  | — |  |  | 2.4 |
Amortization of deferred financing costs |  | 3.1 |  |  | — |  |  | — |  |  | 3.1 |
Deferred income taxes |  | 23.0 |  |  | 2.5 |  |  | — |  |  | 25.5 |
Other |  | 13.0 |  |  | — |  |  | — |  |  | 13.0 |
Changes in operating assets and liabilities: |  |  |  |  |  |  |  |
Accounts receivable |  | 76.2 |  |  | — |  |  | 6.3 |  |  | 82.5 |
Inventories |  | (112.2) |  |  | — |  |  | 9.4 |  |  | (102.8) |
Prepaid expenses and other assets |  | (29.2) |  |  | — |  |  | (5.1) |  |  | (34.3) |
Accounts payable |  | (9.0) |  |  | — |  |  | (2.8) |  |  | (11.8) |
Accrued expenses and other liabilities |  | (47.8) |  |  | — |  |  | (0.6) |  |  | (48.4) |
Accrued compensation |  | (5.7) |  |  | — |  |  | — |  |  | (5.7) |
Income taxes receivable and payable, net |  | (50.2) |  |  | (0.8) |  |  | — |  |  | (51.0) |
Contract liabilities |  | 4.2 |  |  | — |  |  | — |  |  | 4.2 |
Net cash used in operating activities |  | (126.9) |  |  | — |  |  | — |  |  | (126.9) |
Investing Activities |  |  |  |  |  |  |  |
Purchases of property, plant and equipment |  | (92.2) |  |  | — |  |  | — |  |  | (92.2) |
Asset acquisitions |  | (243.7) |  |  | — |  |  | — |  |  | (243.7) |
Net cash used in investing activities |  | (335.9) |  |  | — |  |  | — |  |  | (335.9) |
Financing Activities |  |  |  |  |  |  |  |
Purchases of treasury stock |  | (81.9) |  |  | — |  |  | — |  |  | (81.9) |
Proceeds from revolving credit facility |  | 238.0 |  |  | — |  |  | — |  |  | 238.0 |
Principal payments on term loan facility |  | (25.3) |  |  | — |  |  | — |  |  | (25.3) |
Proceeds from stock-based compensation activity |  | 3.0 |  |  | — |  |  | — |  |  | 3.0 |
Taxes paid for stock-based compensation activity |  | (5.7) |  |  | — |  |  | — |  |  | (5.7) |
Net cash provided by financing activities: |  | 128.1 |  |  | — |  |  | — |  |  | 128.1 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | (0.6) |  |  | — |  |  | — |  |  | (0.6) |
Net change in cash, cash equivalents and restricted cash |  | (335.3) |  |  | — |  |  | — |  |  | (335.3) |
Cash, cash equivalents and restricted cash, beginning of period |  | 576.3 |  |  | — |  |  | — |  |  | 576.3 |
Cash, cash equivalents and restricted cash, end of period |  | $ | 241.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 241.0 |
Supplemental disclosure of cash flow information: |  |  |  |  |  |  |  |
Cash paid for interest |  | $ | 26.7 |  |  | $ | — |  |  | $ | — |  |  | $ | 26.7 |
Cash paid for income taxes |  | $ | 23.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 23.9 |
Supplemental information on non-cash investing and financing activities: |  |  |  |  |  |  |  |
Purchases of property, plant and equipment unpaid at period end |  | $ | 10.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 10.0 |
Reconciliation of cash and cash equivalents and restricted cash: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 240.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 240.9 |
Restricted cash |  | 0.1 |  |  | — |  |  | — |  |  | 0.1 |
Total |  | $ | 241.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 241.0 |
The following table presents the impact of the financial statement adjustments on the Company's previously reported Quarterly Condensed Consolidated Statements of Operations for the three months ended March 31, 2022 and June 30, 2022:
|  | Three Months Ended |  | Three Months Ended
| March 31, 2022 |  | June 30, 2022
| Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised |  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised
Total revenues |  | $ | 307.5 |  |  | $ | — |  |  | $ | (2.7) |  |  | $ | 304.8 |  |  | $ | 242.7 |  |  | $ | — |  |  | $ | (0.1) |  |  | $ | 242.6 |
Cost of product sales |  | $ | 80.3 |  |  | $ | — |  |  | $ | (0.9) |  |  | $ | 79.4 |  |  | $ | 91.0 |  |  | $ | — |  |  | $ | 1.2 |  |  | $ | 92.2 |
Cost of CDMO |  | $ | 75.6 |  |  | $ | — |  |  | $ | (1.6) |  |  | $ | 74.0 |  |  | $ | 78.8 |  |  | $ | — |  |  | $ | 1.0 |  |  | $ | 79.8 |
Income (loss) from operations |  | $ | 6.4 |  |  | $ | — |  |  | $ | 0.5 |  |  | $ | 6.9 |  |  | $ | (72.0) |  |  | $ | — |  |  | $ | (4.3) |  |  | $ | (76.3) |
Net income (loss) |  | $ | (3.7) |  |  | $ | (1.4) |  |  | $ | 0.5 |  |  | $ | (4.6) |  |  | $ | (56.4) |  |  | $ | 7.8 |  |  | $ | (4.3) |  |  | $ | (52.9) |
Net income (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.07) |  |  | $ | (0.03) |  |  | $ | 0.01 |  |  | $ | (0.09) |  |  | $ | (1.13) |  |  | $ | 0.16 |  |  | $ | (0.09) |  |  | $ | (1.06) |
Diluted |  | $ | (0.07) |  |  | $ | (0.03) |  |  | $ | 0.01 |  |  | $ | (0.09) |  |  | $ | (1.13) |  |  | $ | 0.16 |  |  | $ | (0.09) |  |  | $ | (1.06) |
The following table presents the impact of the financial statement adjustments on the Company's previously reported Quarterly Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and June 30, 2023:
|  | Three Months Ended |  | Three Months Ended
| March 31, 2023 |  | June 30, 2023
| Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised |  | Previously Reported |  | Tax Adjustments |  | Other Adjustments |  | As Revised
Total revenues |  | $ | 165.1 |  |  | $ | — |  |  | $ | (0.8) |  |  | $ | 164.3 |  |  | $ | 337.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 337.9 |
Cost of product sales |  | $ | 102.9 |  |  | $ | — |  |  | $ | (1.7) |  |  | $ | 101.2 |  |  | $ | 134.9 |  |  | $ | — |  |  | $ | — |  |  | $ | 134.9 |
Cost of CDMO |  | $ | 52.2 |  |  | $ | — |  |  | $ | (0.5) |  |  | $ | 51.7 |  |  | $ | 55.7 |  |  | $ | — |  |  | $ | — |  |  | $ | 55.7 |
Income (loss) from operations |  | $ | (148.1) |  |  | $ | — |  |  | $ | 0.5 |  |  | $ | (147.6) |  |  | $ | (292.9) |  |  | $ | — |  |  | $ | — |  |  | $ | (292.9) |
Net income (loss) |  | $ | (183.0) |  |  | $ | (3.7) |  |  | $ | 0.5 |  |  | $ | (186.2) |  |  | $ | (261.3) |  |  | $ | (0.1) |  |  | $ | — |  |  | $ | (261.4) |
Net income (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (3.65) |  |  | $ | (0.07) |  |  | $ | 0.01 |  |  | $ | (3.71) |  |  | $ | (5.15) |  |  | $ | (0.01) |  |  | $ | — |  |  | $ | (5.16) |
Diluted |  | $ | (3.65) |  |  | $ | (0.07) |  |  | $ | 0.01 |  |  | $ | (3.71) |  |  | $ | (5.15) |  |  | $ | (0.01) |  |  | $ | — |  |  | $ | (5.16) |

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration